Estrogen receptor-β signaling modulates epithelial barrier function

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 300, Issue 4, 2011, Pages

  Langen, Mirjam Looijer van ^b   Hotte, Naomi ^a   Dieleman, Levinus A ^a   Albert, Eric ^a   Mulder, Chris ^b   Madsen, Karen L ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Estrogen receptor ; Inflammation; Inflammatory bowel disease; Intestinal permeability

Indexed keywords

CYTOKINE; DIARYLPROPIONITRILE; ESTRADIOL; ESTROGEN RECEPTOR BETA; FULVESTRANT; HLA B27 ANTIGEN; INTERLEUKIN 10; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; COLON BIOPSY; CONTROLLED STUDY; CROHN DISEASE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; INTESTINE EPITHELIUM; INTESTINE MUCOSA PERMEABILITY; MALE; MONOLAYER CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIGHT JUNCTION;

ANALYSIS OF VARIANCE; ANIMALS; CELL LINE; CELLS, CULTURED; COLON; EPITHELIAL CELLS; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR BETA; FEMALE; HLA-B27 ANTIGEN; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTESTINAL MUCOSA; MALE; MICE; MICE, KNOCKOUT; NITRILES; PERMEABILITY; PROPIONATES; RATS; RATS, TRANSGENIC; RNA, MESSENGER;

EID: 79955076206     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00274.2010     Document Type: Article

References (36)

1. Aberdeen GW, Wiegand SJ, Bonagura TW II, Pepe GJ, Albrecht ED. Vascular endothelial growth factor mediates the estrogen-induced breakdown of tight junctions between and increase in proliferation of microvessel endothelial cells in the baboon endometrium. Endocrinology 149: 6076-6083, 2008.
2. Arai N, Strom A, Rafter JJ, Gustafsson JA. Estrogen receptor β mRNA in colon cancer cells: growth effects of estrogen and genistein. Biochem Biophys Res Commun 270: 425-431, 2000.
3. Arnott ID, Kingstone K, Ghosh S. Abnormal intestinal permeability predicts relapse in inactive Crohn's disease. Scand J Gastroenterol 35: 1163-1169, 2000.
4. Arrieta M, Doyle J, Madsen K, Meddings J. Reducing small intestinal permeability attenuates colitis in the IL-10 gene deficient mouse. Gut 58: 41-48, 2009.
5. Boyko EJ, Theis MK, Vaughan TL, Nicol-Blades B. Increased risk of inflammatory bowel disease associated with oral contraceptive use. Am J Epidemiol 140: 268-278, 1994.
6. Campbell-Thompson M, Lynch IJ, Bhardwaj B. Expression of estrogen receptor (ER) subtypes and ERβ isoforms in colon cancer. Cancer Res 61: 632-640, 2001.
7. Clarkson T. Measurement of short-circuit current and ion transport across the ileum. Am J Physiol 206: 658-668, 1964.
8. Cornish JA, Tan E, Simillis C, Clark SK, Teare J, Tekkis PP. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol 103: 2394-2400, 2008.
9. Dahlman-Wright K, Cavailles V, Fuqua SA, Jordan VC, Katzenellenbogen JA, Korach KS, Maggi A, Muramatsu M, Parker MG, Gustafsson JA. International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev 58: 773-781, 2006.
10. El-Tawil AM. Oestrogens and Crohn's disease: the missed link. Andrologia 40: 141-145, 2008.
11. Ewaschuk J, Diaz H, Meddings L, Diederichs B, Dmytrash A, Backer J, Looijer-van Langen M, Madsen KL. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol 295: G1025-G1034, 2008.
12. Gorodeski GI. Estrogen decrease in tight junctional resistance involves matrix-metalloproteinase-7-mediated remodeling of occludin. Endocrinology 148: 218-231, 2007.
13. Gunal O, Oktar BK, Ozcinar E, Sungur M, Arbak S, Yegen B. Estradiol treatment ameliorates acetic acid-induced gastric and colonic injuries in rats. Inflammation 27: 351-359, 2003.
14. Harnish DC, Albert LM, Leathurby Y, Eckert AM, Ciarletta A, Kasaian M, Keith JC Jr. Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 286: G118-G125, 2004.
15. Harris HA. Estrogen receptor-β: recent lessons from in vivo studies. Mol Endocrinol 21: 1-13, 2007.
16. Hollander D, Vadheim CM, Brettholz E, Petersen GM, Delahunty T, Rotter JI. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann Intern Med 105: 883-885, 1986.
17. Houdeau E, Moriez R, Leveque M, Salvador-Cartier C, Waget A, Leng L, Bueno L, Bucala R, Fioramonti J. Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat. Gastroenterology 132: 982-993, 2007.
18. Kane SV, Reddy D. Hormonal replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease. Am J Gastroenterol 103: 1193-1196, 2008.
19. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol 28: 573-621, 2010.
20. Katz KD, Hollander D, Vadheim CM, McElree C, Delahunty T, Dadufalza VD, Krugliak P, Rotter JI. Intestinal permeability in patients with Crohn's disease and their healthy relatives. Gastroenterology 97: 927-931, 1989.
21. Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andricopoulos P, Varakis I, Sotiropoulou-Bonikou G, Papavassiliou AG. Oestrogen receptor-β (ERβ) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer 39: 1251-1258, 2003.
22. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93: 5925-5930, 1996.
23. Lee SH, Nam HS. TNF-α-induced down-regulation of estrogen receptor-α in MCF-7 breast cancer cells. Mol Cells 26: 285-290, 2008.
24. -{increment}{increment}CT method. Methods 25: 402-408, 2001.
25. Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L, De Simone C. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121: 580-591, 2001.
26. Madsen KL, Doyle JS, Jewell LD, Tavernini MM, Fedorak RN. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116: 1107-1114, 1999.
27. Meddings JB, Sutherland LR, May GR. Intestinal permeability in patients with Crohn's disease. Gut 35: 1675-1676, 1994.
28. Munkholm P, Langholz E, Hollander D, Thornberg K, Orholm M, Katz KD, Binder V. Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives. Gut 35: 68-72, 1994.
29. Prasad AS. Zinc in human health: effect of zinc on immune cells. Mol Med 14: 353-357, 2008.
30. Rennick DM, Fort MM. Lessons from genetically engineered animal models. XII. IL-10-deficient IL-10(-/-) mice and intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 278: G829-G833, 2000.
31. T method. Nat Protoc 3: 1101-1108, 2008.
32. Snyder MA, Smejkalova T, Forlano PM, Woolley CS. Multiple ERβ antisera label in ERβ knockout and null mouse tissues. J Neurosci Methods 188: 226-234, 2010.
33. Soderholm JD, Olaison G, Peterson KH, Franzen LE, Lindmark T, Wiren M, Tagesson C, Sjodahl R. Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease. Gut 50: 307-313, 2002.
34. Stallmach A, Giese T, Schmidt C, Ludwig B, Mueller-Molaian I, Meuer SC. Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn's disease. Int J Colorectal Dis 19: 308-315, 2004.
35. Wada-Hiraike O, Imamov O, Hiraike H, Hultenby K, Schwend T, Omoto Y, Warner M, Gustafsson JA. Role of estrogen receptor beta in colonic epithelium. Proc Natl Acad Sci USA 103: 2959-2964, 2006.
36. Wada-Hiraike O, Warner M, Gustafsson JA. New developments in oestrogen signalling in colonic epithelium. Biochem Soc Trans 34: 1114-1116, 2006.